Novartis Ag NVS
NYSE NVS
$143.44 -2.27 (-1.56%)
As of: Sep 30, 2026 · 2:35 PM EDT

Novartis Ag (NVS) Notes Payables (2016 - 2025)

Updated

Novartis Ag's Notes Payables was $682 million in Q4 2025, up 6.2% from $642 million a year earlier.

Analysis

Novartis Ag (NVS) Notes Payables (2016 - 2025) Analysis & Trends

From Q4 2016 onward, Novartis Ag has reported Notes Payables for 10 quarters.

  • Notes Payables shows a five-year compound annual growth rate of -6.9% (FY2020 to FY2025).
  • In earlier years, Notes Payables was $642 million in FY2024 (+2.9%), $624 million in FY2023 (-27.7%), $863 million in FY2022 (-4.0%) and $899 million in FY2021 (-7.9%).
  • The Q4 2025 figure marks the highest quarterly Notes Payables since Q4 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn
10 Bristol Myers Squibb 128.45 Bn 79.72 Bn 9.25 Bn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 682.00 Mn
Dec 31, 2024 642.00 Mn
Dec 31, 2023 624.00 Mn
Dec 31, 2022 863.00 Mn
Dec 31, 2021 899.00 Mn
Dec 31, 2020 976.00 Mn
Dec 31, 2019 719.00 Mn
Dec 31, 2018 701.00 Mn
Dec 31, 2017 692.00 Mn
Dec 31, 2016 836.00 Mn
API Access

Novartis Ag Notes Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=notes-payables&ticker=NVS&period=max&api_key=YOUR_API_KEY